Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

10592studies shown

Showing 9,253-9,264 of 10,592

Drug study icon

CompletedNCT00586157

Medication Patch to Treat Children Ages 6-12 With ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 6 Years to 12 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: ADHD

Other study type icon

CompletedNCT00869505

Memantine Augmentation in Severe OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDOtherOver 18 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: OCD

Drug study icon

CompletedNCT00984360

Naltrexone for Methamphetamine Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: California Pacific Medical Center Research Institute
Condition: Addiction

Drug study icon

TerminatedNCT00515255

NPL-2003 in Adolescents With OCD (OCD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDDrugFrom 12 Years to 17 Years

Countries: United States
Sponsor: Neuropharm
Condition: OCD

Behavioral study icon

CompletedNCT02674711

Opioid Use After Lumbar and Cervical Spine Surgery

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Brooke Army Medical Center
Condition: Addiction

Drug study icon

CompletedNCT06605599

ABBV-932 to Assess Adverse Events and Change for Bipolarity

This study is completed in the United States and in Japan. It is testing ABBV-932 to Assess Adverse Events and Change for Bipolarity.

In United States

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States, Japan
Sponsor: AbbVie
Condition: Bipolarity

Drug study icon

CompletedNCT00057681

Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 6 Years to 15 Years

Countries: United States
Sponsor: Washington University School of Medicine
Condition: Bipolarity

Drug study icon

CompletedNCT01515423

Paliperidone Palmitate 3 Month and 1 Month Formulations for people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 70 Years

Countries: United States, Australia, France, ...
Sponsor: Janssen Research & Development, LLC
Condition: Schizophrenia

Drug study icon

CompletedNCT00056472

Pharmacotherapy of Psychotic Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, SchizophreniaDrugOver 18 Years

Countries: United States, Canada
Sponsor: Weill Medical College of Cornell University
Condition: Depression, Schizophrenia

Other study type icon

CompletedNCT01208844

Physical Health for Women With Posttraumatic Stress or Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionOtherFrom 18 Years to 50 Years

Countries: United States
Sponsor: Nova Southeastern University
Condition: Depression

Drug study icon

TerminatedNCT00772785

Probuphine in people with Opioid Dependence

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Titan Pharmaceuticals
Condition: Addiction

Other study type icon

CompletedNCT02003352

PTSD in Military Veterans Who Have Suffered Traumatic Brain Injuries

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDOtherFrom 18 Years to 60 Years

Countries: United States
Sponsor: Carrick Institute for Graduate Studies
Condition: PTSD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.